• Main Navigation
  • Account Navigation
  • Main Content
  • ASH Home
  • ASH Store
  • ASH Academy
  • My Cart
  • My Account
  • Sign in
  • Cookie Settings
 To purchase or access the 2020 Annual Meeting Webcasts, please click here
Show Main Menu+
  • About ASH On Demand
  • FAQs
  • Contact Us
  • Catalog
  • Annual Meetings
  • Meetings
    • Meeting on Hematologic Malignancies
    • Consultative Hematology Course
    • Highlights of ASH
    • Education Summaries
  • Free Content
    • Webinars
    • Videos
    • Podcasts
  • My Library
    Check Out
    Minimize
    Home / Meetings

    2016 ASH Meeting on Hematologic Malignancies

    Description

    Access recorded “How I Treat” presentations and topic-based panel discussions from the 2016 ASH Meeting on Hematologic Malignancies. Hear the top experts in the field discuss the latest developments in clinical care, showcase their evidence-based treatment approaches, and provide answers to challenging patient care questions.

    Pricing

    Member Type Price
    List Price $275.00
    Active, International, Emeritus, and Honorary Members $100.00
    Associate, International Associate, Student, and Resident Members $75.00

    Sessions

    Education Program

    • Welcome and Opening Remarks (Day 1)
    • How I Treat Hodgkin Lymphoma
    • How I Treat Follicular Lymphoma
    • How I Treat Mantle Cell Lymphoma
    • Lymphoma Panel Discussion I
    • How I Treat Low Grade MDS
    • How I Treat High Grade MDS
    • MDS Panel Discussion
    • How I Treat Myelofibrosis Patients Who Have “Failed” Ruxolitinib
    • How I Treat High-Risk Patients with Essential Thrombocythemia or Polycythemia Vera
    • How I Treat MPN or CML: Who and When Am I Transplanting?
    • MPN Panel Discussion
    • How I Treat CLL
    • How I Treat CLL: High-Risk Genetics
    • CLL Panel Discussion
    • Welcome and Opening Remarks
    • How I Treat Hypocellular MDS
    • How I Treat Relapsed AML: Do Molecular Genetics Help?
    • MDS/AML Panel Discussion
    • How I Treat ALL in First Complete Remission: Role of MRD and Molecular Genetics in Treatment Decisions
    • How I Treat ALL in Older Adults: Ph+ and Ph- ALL
    • ALL Panel Discussion
    • How I Treat Diffuse Large B-Cell and Mediastinal Large Cell Lymphomas
    • How I Treat Highly Aggressive Lymphomas: Burkitt, Double-Hit, B-Cell, and Unclassifiable with Features Intermediate between DLBCL and Burkitt Lymphoma
    • Lymphoma Panel Discussion II
    • How I Treat Myeloma Using Genomic Analysis
    • How I Treat Newly Diagnosed Multiple Myeloma
    • How I Treat Relapsed/Refractory Myeloma Including Novel Agents
    • Myeloma Panel Discussion
    • Closing Remarks and Adjournment
    back to top
    placeholder + image

    62nd ASH Virtual Annual Meeting

    December 5-8, 2020
    Virtual Experience

    Learn more
    placeholder + image

    ASH Meeting on Hematologic Malignancies

    Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.

    Learn more

    AMERICAN SOCIETY OF HEMATOLOGY

    2021 L Street NW, Suite 900, Washington, DC 20036

    Phone 202-776-0544 | Fax 202-776-0545

    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    • facebook
    • twitter
    • linkedin

    Copyright © 2021 by American Society of Hematology

    Privacy Policy |Terms of Service |Contact Us